Skip to main content Skip to section navigation Skip to footer
Careers News & Media Contact
OPKO Health, Inc. OPKO Health, Inc.
  • Therapies
    • Overview
    • Ngenla
    • Rayaldee
  • Research
    • Overview
    • Pipeline
    • Publications
    • Scientific Presentations
  • Diagnostics
  • Company
    • Overview
    • Leadership
    • Locations
  • Partnerships
  • Investors
    • Overview
    • News / Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • News & Media
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations
Nov 15, 2013 8:00am EST

OPKO Completes Patient Recruitment in First Phase 3 Trial of RayaldyTM

Nov 11, 2013 12:37pm EST

OPKO Announces Third Quarter 2013 Financial and Operating Highlights

Nov 06, 2013 3:51pm EST

Neovasc, an OPKO Supported Company, Reports That Reducer™ Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Function in Patients with Refractory Angina

Nov 04, 2013 8:51am EST

OPKO Commences Pivotal Clinical Validation Study for 4Kscore™ as a Predictor of Prostate Cancer Prior to Biopsy

Oct 21, 2013 1:11pm EDT

OPKO Obtains Final Marketing Authorization for Citicoline in Spain

Oct 10, 2013 9:00am EDT

OPKO Adds to Growing Technology Portfolio Through Strategic Investment in Biotechnology Company Engaged in the Development of a New Generation of Antibodies

Aug 30, 2013 9:07am EDT

Conversion Right Triggered on OPKO 3.0% Convertible Senior Notes

Aug 28, 2013 8:25am EDT

OPKO Health Announces Listing in Major Indices on Tel Aviv Stock Exchange

Aug 19, 2013 7:00am EDT

OPKO Health Announces New Listing on Tel Aviv Stock Exchange

Aug 15, 2013 12:18pm EDT

OPKO Surpasses 50% Enrollment in Second Phase 3 Trial of Rayaldy™

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • …
  • Page 52
  • Next Pagearrow_forward
rss_feed News RSS

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137


T: 305-575-4100
contact@opko.com

©2025 OPKO Health, Inc. All Rights Reserved.
Privacy Policy Governance Terms of use Sitemap